Biophytis

company

About

Biophytis is a research company that focuses on the fields of metabolic and age-related diseases.

  • 11 - 50

Details

Last Funding Type
Post-IPO Debt
Last Funding Money Raised
€10M
Industries
Biotechnology,Nutraceutical,Pharmaceutical
Founded date
Jan 1, 2006
Number Of Employee
11 - 50
Operating Status
Active

Biophytis is a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases.


Their goal is to become a leader in the emerging field of aging science by delivering life-changing therapies to the growing number of patients in need that have limited or no treatment options.

To accomplish this goal, they have assembled an experienced and skilled group of industry professionals, scientists, clinicians and key opinion leaders from leading industry and academic institutions from around the world.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€10M
Biophytis has raised a total of €10M in funding over 2 rounds. Their latest funding was raised on Nov 22, 2021 from a Post-IPO Debt round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 22, 2021 Post-IPO Debt €10M 1 Kreos Capital Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Biophytis is funded by 1 investors. Kreos Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Kreos Capital Yes Post-IPO Debt